XML 31 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurement on a Recurring Basis (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Measurement on a Recurring Basis [Abstract]  
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025, and indicate the fair value hierarchy of the inputs that the Company utilized to determine such fair value.

Description  Quoted
Prices in Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total 
Assets:                
Assets held in Trust Account – U.S. government debt securities  $209,374,139   $
    —
   $
   $209,374,139 
Total  $209,374,139   $
   $
   $209,374,139 
Liabilities:                    
Forward sale securities liability  $
   $
   $18,903,254   $18,903,254 
Total  $
   $
   $18,903,254   $18,903,254 

 

December 31, 2025

 

Description  Quoted
Prices in Active
Markets
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Other
Unobservable
Inputs
(Level 3)
   Total 
Assets:                
Assets held in Trust Account – U.S. government debt securities  $207,513,472   $
    —
   $
   $207,513,472 
Total  $207,513,472   $
   $
   $207,513,472 
Liabilities:                    
Forward sale securities liability  $
   $
   $13,196,864   $13,196,864 
Total  $
   $
   $13,196,864   $13,196,864 
Schedule of Change in the Fair Value of the Forward Sale Securities

The following table presents the change in the fair value of the forward sale securities liability for the three months ended March 31, 2026:

 

   Forward Sale
Securities
 
Fair value as of December 31, 2025  $(13,196,864)
Change in valuation inputs or other assumptions(1)   (5,706,390)
Fair value as of March 31, 2026  $(18,903,254)

 

(1)Changes in valuation inputs or other assumptions are recognized in Change in fair value of forward sale securities in the unaudited condensed consolidated statements of operations.